Conference Details
2008 Best Practices in Primary Care
10/25/2008
|
|
Hilton Pittsburgh
600 Commonwealth Place
Pittsburgh
,
PA
15222
Phone:
412-391-4600
Who Should Attend
All primary care clinicians (physicians, physician assistants, and nurse practitioners) who are active in patient care.
Agenda
| |
| 10/25/2008 |
| 6:30 am - 7:30 am |
Registration and Complimentary Continental Breakfast |
| 7:30 am - 12:00 pm |
Sessions 1, 2, & 3 (each session followed by a 10-15 minute break) |
| 12:00 pm - 12:30 pm |
Complimentary Lunch |
| 12:30 pm - 4:45 pm |
Sessions 4, 5 & 6 (each session followed by a 5-15 minute break) |
|
Venue Information
Meeting Room: Grand Ballroom II, III, IV
Parking: Self parking is $21.25, Valet parking is $25.
A limited number of rooms have been reserved at the Hilton Pittsburgh at a rate of $129 per night. For reservations, call 412-391-4600 and mention the Primary Care Education Network room block. Reservations must be made by September 24, 2008 in order to receive the discounted rate.
Accreditation
ACCME
Primary Care Network, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Primary Care Network designates this educational activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
AAFP
Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.
AANP
This program is pending CE approval by the American Academy of Nurse Practitioners.
AAPA
AAPA accepts Category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by ACCME.
Topics
| |
| | Rheumatoid Arthritis | | | The Triangle of Treatment: Taking a Team Approach to Managing Rheumatoid Arthritis
Overview Rheumatoid arthritis (RA) is a complex immunologic and chronic inflammatory disease that affects more than 2 million people in the United States. Characterized by inflammation of the joints, periarticular bone resorption and cartilage destruction, RA is also an inherently aggressive, systemic disease that leaves patients vulnerable to comorbidities such as cardiovascular disease, osteoporosis, lymphoma, infection, and stroke. While primary care clinicians may not directly treat the disease long term, they are the first to come in contact with potential RA patients. Therefore it is important for all clinicians to be aware of the necessary steps in RA diagnostic and treatment modalities.
Objectives Identify 3 early warning signs of rheumatoid arthritis (RA)
Describe current and evolving treatment options for RA, and be alert to monitoring and side effects related to these therapies
Faculty Kevin Latinis, MD, PhD Associate Division Director Assistant Professor The University of Kansas Medical Center Department of Internal Medicine Kansas City, KS
| | | Diabetes | | | Taking Control of Glycemia in Type 2 Diabetes Patients with Cardiovascular Risk
Overview More than 20 million people in the United States are affected by diabetes, with 1.5 million new cases appearing each year. Of this population, nearly 65% will die from heart disease or stroke, a rate that is 4-times higher than in the non-diabetic population. Individualized and early glycemic control is critical in the prevention and management of diabetes and in reducing cardiovascular risk. This activity will expose attendees to the relationship between insulin resistance, type 2 diabetes, and the resulting cardiovascular risk in an effort to uncover effective treatment strategies and patient-based therapeutic options.
Objectives Utilize appropriate glucose-lowering agents to reduce A1C to * 7.0%
Minimize adverse events and cardiovascular risk associated with glycemic therapy by employing appropriate glucose, blood pressure, and serum cholesterol agents
Faculty
| | | Insomnia | | | Insomnia: New Directions in Evaluation and Treatment
Overview Despite a high prevalence in the United States, insomnia remains underdiagnosed and undertreated. Extensive research has identified several factors that contribute to the inadequate treatment of insomnia, including the failure of patients to report insomnia to clinicians and clinician misperceptions about the risks associated with hypnotic medications. This program will address effective strategies for diagnosing and treating patients with insomnia.
Objectives Identify risk factors, determine appropriate screening tools, and accurately diagnose insomnia
Evaluate current and emerging nonpharmacologic and pharmacologic therapies for acute and chronic insomnia on the basis of efficacy and safety and apply this knowledge/skill with patients
Faculty
| | | Dyslipidemia | | | The Moving LDL Target: Getting Your Patients to Goal
Overview The current use of lipid lowering therapy in clinical practice has fallen short of the recommendations of national guidelines. Clearly, not an easy venture when treating patients with dyslipidemia, many with multiple risk factors and many with resulting coronary events that may be preventable if patients were treated aggressively to meet the NCEP-ATP lll goals. This presentation will address the clinical challenges of goal attainment (lack of compliance, aggressive treatment by clinicians, not leaving patients 15 points from goals), and provide clinicians with the pathways and knowledge to help attain their patients to goal.
Objectives Describe at least two challenges in treating dyslipidemia to NCEP-ATP III goals, implement strategies that will help to assess CHD risk accurately, and get patients to targeted goals
Identify patients at increased risk for cardiovascular events and develop a treatment plan with at least 2 lipid lowering strategies, including the use of multiple therapies, which will help these patients achieve guideline-based targets taking into consideration current lifestyle and pharmacologic treatment options available thus reducing overall cardiovascular risk
Faculty Emma Meagher, MD Associate Professor, Medicine and Pharmacology Executive Chair University of Pennsylvania, School of Medicine Philadelphia, PA
Ronald A. Codario, MD, FACP Clinical Instructor in Medicine Thomas Jefferson University Hospital Philadelphia, PA
| | | | | | Topic Title
Overview
Objectives Faculty
|
|